Fludarabine AHP injection 50mg

About Fludarabine AHP injection 50mg

Fludarabine AHP Injection Uses

• B-cell chronic lymphocytic leukemia (CLL)
• CLL that has not responded to, or has returned after, another treatment
• Some types of non-Hodgkin lymphoma, as decided by an oncologist
• Preparation before stem cell transplant in selected patients

Fludarabine AHP Injection Benefits

• Can shrink leukemia cells and improve blood counts
• Works as part of combination chemotherapy plans
• Given in planned cycles by a specialist team

What Experts Say

Fludarabine is a purine analog that interferes with DNA production in fast dividing cancer cells. It is a standard option for chronic lymphocytic leukemia. Newer targeted drugs are now used in some patients, but fludarabine is still an important option. Blood counts usually reach their lowest point some weeks after a cycle.

Oncologists often combine it with other drugs such as cyclophosphamide or rituximab. Treatment is given in cycles, with regular blood tests before each dose. Preventive antibiotics or antivirals are sometimes given during treatment. Response is checked with blood tests and clinical examination during treatment.

It strongly lowers blood counts and immunity, so infection and bleeding are watched closely. Doses are reduced in kidney disease, and only experienced cancer teams should give it. Blood transfusions during therapy should use irradiated blood products. Regular hospital visits for blood tests are a routine and essential part of care.

Drug Class

• Antimetabolite (purine analog) chemotherapy
• Antineoplastic agent

Fludarabine AHP injection 50mg formula

• Fludarabine phosphate

Available forms

• Injection

How to use Fludarabine AHP injection 50mg?

• Fludarabine is given only by a doctor or trained provider in a hospital, into a vein.
• The oncologist calculates the dose from body size and kidney function.
• Cycles are usually repeated every four weeks, with blood tests before each cycle.
• Report fever, bleeding, breathlessness or confusion to the care team at once.

Drug Interactions

• Pentostatin: Combining it with fludarabine can cause fatal lung toxicity and must be avoided.
• Live vaccines: Weak immunity during treatment makes live vaccines unsafe.
• Other bone marrow suppressing drugs: Can worsen low blood counts.
• Dipyridamole: May reduce the effectiveness of fludarabine.

Risks and warnings

• Bone marrow suppression: Severe drops in white cells, platelets and red cells can cause infection, bleeding and anemia.
• Nervous system toxicity: High doses can cause blindness, confusion, seizures and coma.
• Autoimmune hemolytic anemia: Some patients develop life threatening destruction of red blood cells.
• Kidney problems: Dose is lowered in reduced kidney function, and kidney tests are monitored.
• Pregnancy and vaccines: Avoid pregnancy during treatment and avoid live vaccines.

Fludarabine AHP Injection Side Effects

• Low white blood cell counts with infections
• Fever and chills
• Nausea and vomiting
• Tiredness and weakness
• Low red cells (anemia) and low platelets
• Cough or breathlessness
• Numbness or tingling
• Diarrhea

Storage Conditions

• Store vials refrigerated at 2 to 8 degrees Celsius unless the pack states otherwise.
• Protect from light and do not freeze.
• Handle and discard as cytotoxic waste.
• Keep out of reach of children.